Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T20:42:17.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T20:48:38.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Access to the study record now returns a 403 Forbidden error instead of loading the study details. This indicates a permission or server issue rather than a content update.
    Difference
    17%
    Check dated 2026-09-20T20:20:39.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.5 to v3.6.6, signaling a new build of the page. This represents minor metadata or UI changes rather than substantive changes to study data.
    Difference
    0.1%
    Check dated 2026-08-30T21:38:58.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The release notes footer now shows Revision: v3.6.5, replacing v3.6.4, indicating a small build update. This change does not alter the study details or how the page functions.
    Difference
    0.1%
    Check dated 2026-08-09T08:22:56.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.4, replacing v3.6.3, indicating a small update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-07-25T18:24:00.000Z thumbnail image

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.